PDS Biotechnology (PDSB) Stock Statistics & Valuation Metrics

PDS Biotechnology has a market cap or net worth of $49.85M. The enterprise value is $47.71M.

PDS Biotechnology has 47,025,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

PDS Biotechnology’s return on equity (ROE) is -1.98 and return on invested capital (ROIC) is -86.94%.

The current PE Ratio of PDS Biotechnology is ―. PDS Biotechnology’s PEG ratio is 0.06.

In the last 12 months, PDS Biotechnology had revenue of 0.00 and earned -37.61M in profits. Earnings per share was -1.03.

In the last 12 months, operating cash flow was -34.37M and capital expenditures 0.00, giving a free cash flow of -34.37M billion.

PDS Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

PDS Biotechnology upcoming earnings date is Nov 12, 2025, TBA (Confirmed).

PDS Biotechnology as a current ratio of 2.64, with Debt / Equity ratio of 116.15%

In the past 12 months, PDS Biotechnology has paid -869.00K in taxes.

PDS Biotechnology EV to EBITDA ratio is -1.17, with an EV/FCF ratio of -1.13.

PDS Biotechnology has $31.87M in cash and marketable securities with $18.54M in debt, giving a net cash position of $13.34M billion.

Gross margin is -26.84%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for PDS Biotechnology is $13.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy